- Home
- APGE vs S Comparison
APGE vs S Comparison
Compare APGE & S Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | S |
|---|---|---|
| Founded | 2022 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.8B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APGE | S |
|---|---|---|
| Price | $82.62 | $15.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 31 |
| Target Price | ★ $109.67 | $19.28 |
| AVG Volume (30 Days) | 517.2K | ★ 6.4M |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,001,278,000.00 |
| Revenue This Year | N/A | $22.84 |
| Revenue Next Year | N/A | $17.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 21.89 |
| 52 Week Low | $34.34 | $11.81 |
| 52 Week High | $95.32 | $21.40 |
Technical Indicators
Market Signals| Indicator | APGE | S |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 59.63 |
| Support Level | $80.52 | $14.64 |
| Resistance Level | $84.56 | $17.18 |
| Average True Range (ATR) | 3.55 | 0.65 |
| MACD | -0.73 | 0.14 |
| Stochastic Oscillator | 15.72 | 69.80 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About S SentinelOne Inc.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.